Biphasic insulin aspart vs Gliclazide
National NHS prescribing compared (Prescription Cost Analysis)
Gliclazide was dispensed 9.8× as often as Biphasic insulin aspart in March 2026 — 488,027 items versus 49,836 in England.
49,836items
Biphasic insulin aspart · March 2026
NHSBSA Prescription Cost Analysis
488,027items
Gliclazide · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Biphasic insulin aspart versus Gliclazide: national items dispensed by month
▬ Biphasic insulin aspart · ╌ Gliclazide
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Biphasic insulin aspart | Gliclazide |
|---|---|---|
| Items, March 2026 | 49,836 | 488,027 |
| Items, last 12 months | 618,619 | 5,853,611 |
| Net ingredient cost, March 2026 | £2,365,581 | £924,868 |
See the full profile for Biphasic insulin aspart or Gliclazide.